Category Archives: DMAA Supplements

Featured Stories

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

81-year-old Port Jefferson Station man was killed in a crash at 4:57 a.m.. He lost control of the vehicle traveling west on Northern State Pkwy, on exit 42, Dix Hills.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Canada’s Federal Health Agency Issues Warning on OxyElite Pro Hepatitis Risk

canada-issues-oxy-elite-pro-warning

Health Canada, Canada’s federal health regulatory agency, has advised Canadians of the  U.S. Food and Drug Administration (FDA) warning not to use dietary supplements labeled as OxyElite Pro following U.S. reports of serious liver injury. USPlabs of Dallas, Texas, has … Continue reading

Posted in DMAA Supplements, Health Concerns, Pharmaceuticals |

Hawaii Liver Failure Cluster may be Tied to Weight Loss/Body Building Supplement

dietary_supplements_liver_failure_

The state of Hawaii is looking into a number of liver failure cases that have occurred in young, healthy adults who all took dietary or nutritional supplements. The state is issuing a public medical alert, according to KHON.com. “A cluster … Continue reading

Posted in Defective Products, DMAA Supplements, Pharmaceuticals |

DMAA Dangers Prompt U.K. to Ban Popular Workout Supplement

The U.K. has become the latest country to outlaw DMAA (1,3-dimethylamylamine), an ingredient used in popular weight loss and body building supplements.  Over the past several months, DMAA has been linked to high blood pressure, headaches, vomiting, stroke and even … Continue reading

Posted in DMAA Supplements, Pharmaceuticals | Tagged |

DMAA Declared Illegal In Ireland

Controversial supplement, DMAA, has been declared illegal in Ireland following a number of incidents worldwide and warnings issued by the U.S. Food & Drug Administration (FDA) in the United States. The Food Safety Authority of Ireland (FSAI) and the Irish … Continue reading

Posted in DMAA Supplements, Pharmaceuticals | Tagged |

Yet Another Study Casts Doubt on DMAA Supplement Claims

A new study is again casting doubt on claims that DMAA (1,3-dimethylamylamine), an ingredient used in popular weight loss and body building supplements, is a naturally-occurring substance found in geraniums.  According to the authors of the study, published in the … Continue reading

Posted in DMAA Supplements, Pharmaceuticals | Tagged |

Insurance Companies Pull Product Liability Coverage for DMAA Supplements

Insurance companies are pulling their product liability coverage for controversial supplement, DMAA. DMAA, or 1,3-dimethylamylamine or methylhexaneamine, received its patent decades ago as a nasal decongestant and is similar in composition to ephedrine and amphetamine. Today, DMAA can be found … Continue reading

Posted in DMAA Supplements, Pharmaceuticals | Tagged |

Study Could End DMAA “Natural” Claims

A new comprehensive study appears to derail any hopes the makers of dietary and workout supplements containing the additive DMAA had to keep their products on the market. According to a report at NutraIngredients-USA.com, the findings have been published in … Continue reading

Posted in DMAA Supplements, Pharmaceuticals | Tagged |

DMAA Class Actions Given Green Light

A DMAA class action lawsuit has been given a green light, which means that makers of DMAA diet supplements will be facing class-action claims against products containing a powerful and controversial stimulant. Nutrex Research and its founders allegedly violated California’s … Continue reading

Posted in Class Action Lawsuits, DMAA Supplements, Toxic Substances | Tagged |

DMAA Supplement Dangers Prompt Investigations, Calls for Ban

DMAA pre-workout and fat-melting supplements have been used by bodybuilders to obtain a sense of energy that many feel provides them with drive and mental focus. The supplement, however, is being criticized by regulators and others over its links to … Continue reading

Posted in DMAA Supplements, Pharmaceuticals | Tagged |

GNC, Vitamin Shoppe Won’t Pull DMAA Supplements

Supplement giants, GNC and the Vitamin Shoppe, refuse to pull DMAA supplements, despite that the U.S. Food & Drug Administration (FDA) has issued a number of warning letters about DMAA-containing products in the past two weeks. Regardless, both GNC and … Continue reading

Posted in DMAA Supplements, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.